TCGA PRAD DEPs Protein and mRNA Expression Data. This spreadsheet contains the patient demographics, tumor characteristics, and protein and mRNA expression data for the 24 age- and stage-matched African-American and Caucasian-American tumors used in this study. Additional sheets present the data of patients used for the non-malignant comparison and the expression values after subtracting the race-specific averaged values from the tumor expression values. (XLSX 23 kb
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Table S1. Metastatic Assay Gene List including Prostate Metastatic Assay gene weightings and bias. T...
Supplementary tables showing the STR profile of the cell lines and the source of antibodies used for...
Additional Analysis on Reproducibility of Protein Fold Changes between Paired Malignant and Non-Mali...
MA Plot. This MA plot shows the data before (a) and after (b) transformation. The variances of the d...
Reproducibility of Protein Fold Changes among Biological Replicates. This figure shows the log2 fold...
In prostate cancer, race/ethnicity is the highest risk factor after adjusting for age. African Ameri...
Figure S1. Processing of proteome data. Figure S2. Overlap in identified proteins between our study ...
Figure S1. Standard GSEA plots of the HALLMARK_ANDROGEN_RESPONSE gene set. Analysis included pre-ran...
r Table S4. Significantly differentially expressed genes without somatic mutations. (XLSX 272 kb
Prostate cancer (PCa) is the leading non-cutaneous malignancy and the second deadliest among America...
Table S1. Comprehensive list of single nucleotide polymorphisms (herein called genetic variants) and...
Table S1. Pathological and clinical data of the arrayed prostate cancers. Table S2. Association betw...
Figure S3. PAGE4 shows low tumor malignancy. a Heat map for several prostate cancer malignancy relat...
Table S2. Comprehensive list of somatic mutations, gene symbols, Ensemble gene IDs, chromosome numbe...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Table S1. Metastatic Assay Gene List including Prostate Metastatic Assay gene weightings and bias. T...
Supplementary tables showing the STR profile of the cell lines and the source of antibodies used for...
Additional Analysis on Reproducibility of Protein Fold Changes between Paired Malignant and Non-Mali...
MA Plot. This MA plot shows the data before (a) and after (b) transformation. The variances of the d...
Reproducibility of Protein Fold Changes among Biological Replicates. This figure shows the log2 fold...
In prostate cancer, race/ethnicity is the highest risk factor after adjusting for age. African Ameri...
Figure S1. Processing of proteome data. Figure S2. Overlap in identified proteins between our study ...
Figure S1. Standard GSEA plots of the HALLMARK_ANDROGEN_RESPONSE gene set. Analysis included pre-ran...
r Table S4. Significantly differentially expressed genes without somatic mutations. (XLSX 272 kb
Prostate cancer (PCa) is the leading non-cutaneous malignancy and the second deadliest among America...
Table S1. Comprehensive list of single nucleotide polymorphisms (herein called genetic variants) and...
Table S1. Pathological and clinical data of the arrayed prostate cancers. Table S2. Association betw...
Figure S3. PAGE4 shows low tumor malignancy. a Heat map for several prostate cancer malignancy relat...
Table S2. Comprehensive list of somatic mutations, gene symbols, Ensemble gene IDs, chromosome numbe...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Table S1. Metastatic Assay Gene List including Prostate Metastatic Assay gene weightings and bias. T...
Supplementary tables showing the STR profile of the cell lines and the source of antibodies used for...